Jeff Hansen

Jeff Hansen

| This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Editor

jeffhans@uab.edu • (205) 209-2355

Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.

Specific beats include: biochemistry; cell, developmental and integrated biology; microbiology; molecular genetics; neurobiology; pathology; pharmacology and tocixology; Alabama Drug Discovery Alliance; Bill L. Harbert Institute for Innovation and Entrepreneurship.

This study of cockroach-induced asthma and Enterobacter mirrors previous studies with fungus- and house dust mite-induced asthma, where neonatal vaccination with bacteria suppressed adult asthma.
UAB researchers will use pressures greater than those found at the center of the Earth to create as yet unknown new materials.
Moon Nahm’s research has led to improvements in testing effectiveness of pneumonia vaccines, a key step to preventing deaths from S. pneumoniae, the leading cause of pneumonia estimated to kill 1.6 million children annually
Learning how sensory organs in the skin work may solve sensory disorders, including pain seen in inflammation, diabetes and cancer treatment.
UAB and UMass researchers have uncovered a new mechanistic understanding of potential treatment for genetic disorders.
The collaboration among UAB, University of Wisconsin and Duke University will use bioengineered stem cells and bioengineered tissue to treat heart failure after heart attacks.
Improved production of stem cells is vital if they are to achieve their promise for medical research and disease treatments like transplantation, creating patient-specific cell-replacement therapies to treat neurological diseases, heart ailments, blood diseases and diabetes.

Computing challenges are found across the UAB campus, from physics and neurology to genetics and the microbiome. Alabama’s most advanced supercomputer is now at UAB, making it possible to solve these challenges. 

A UAB study that is the first of its kind found that a tiny RNA — miR-124-3p — appears to play a role in producing major depression. 

Coating insulin-producing cell-clusters with a thin protective layers may be a way to modify and use pig tissue to ultimately treat human diabetes. Testing in mice is the next step.

Page 41 of 50